Key facts
- Orange Health Labs’s last known valuation is $125.0M (Jun 2022).
- It has raised $47.5M; the latest was Early Stage VC ($12.0M) in Dec 2024.
- Notable investors include Y Combinator, General Catalyst, Pioneer Fund, Accel, Astir Ventures — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Orange Health Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Orange Health Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Orange Health Labs
Operator of a diagnostic lab platform intended to offer affordable home sample collection and test results. The company offers a patient-centric approach to avoid clinic visits for blood tests, checkups, and pathology services, enabling patients with efficient testing and access to healthcare services, and reducing wait times for test results.
- Sector
- Healthcare
- HQ
- Bangalore, India
- Founded
- 2020
- Employees
- 600
- Website
- orangehealth.in/
- Ownership
- Privately Held (backing)
Orange Health Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Orange Health Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Orange Health Labs in its N-PORT filings yet. We sweep new filings monthly.